Beverly Green to Early Detection of Cancer
This is a "connection" page, showing publications Beverly Green has written about Early Detection of Cancer.
Connection Strength
8.497
-
What Multilevel Interventions Do We Need to Increase the Colorectal Cancer Screening Rate to 80%? Clin Gastroenterol Hepatol. 2021 04; 19(4):633-645.
Score: 0.474
-
Financial Incentives to Increase Colorectal Cancer Screening Uptake and Decrease Disparities: A Randomized Clinical Trial. JAMA Netw Open. 2019 07 03; 2(7):e196570.
Score: 0.458
-
Using a continuum of hybrid effectiveness-implementation studies to put research-tested colorectal screening interventions into practice. Implement Sci. 2019 05 29; 14(1):53.
Score: 0.455
-
Implementation successes and challenges in participating in a pragmatic study to improve colon cancer screening: perspectives of health center leaders. Transl Behav Med. 2017 09; 7(3):557-566.
Score: 0.404
-
A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: A randomized trial. Cancer. 2017 Nov 15; 123(22):4472-4480.
Score: 0.401
-
Reasons for never and intermittent completion of colorectal cancer screening after receiving multiple rounds of mailed fecal tests. BMC Public Health. 2017 05 30; 17(1):531.
Score: 0.397
-
Colorectal Cancer Screening Rates Increased after Exposure to the Patient-Centered Medical Home (PCMH). J Am Board Fam Med. 2016 Mar-Apr; 29(2):191-200.
Score: 0.364
-
Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial. Cancer. 2016 Jan 15; 122(2):312-21.
Score: 0.355
-
Factors associated with use and non-use of the Fecal Immunochemical Test (FIT) kit for Colorectal Cancer Screening in Response to a 2012 outreach screening program: a survey study. BMC Public Health. 2015 Jun 11; 15:546.
Score: 0.346
-
An economic evaluation of colorectal cancer screening in primary care practice. Am J Prev Med. 2015 Jun; 48(6):714-21.
Score: 0.345
-
"BeneFITs" to increase colorectal cancer screening in priority populations. JAMA Intern Med. 2014 Aug; 174(8):1242-3.
Score: 0.326
-
Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial. Prev Med. 2014 Sep; 66:123-30.
Score: 0.323
-
Strategies and Opportunities to STOP Colon Cancer in Priority Populations: design of a cluster-randomized pragmatic trial. Contemp Clin Trials. 2014 Jul; 38(2):344-9.
Score: 0.323
-
Time to screening in the systems of support to increase colorectal cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2014 Aug; 23(8):1683-8.
Score: 0.322
-
Navigating the murky waters of colorectal cancer screening and health reform. Am J Public Health. 2014 Jun; 104(6):982-6.
Score: 0.319
-
Strategies and opportunities to STOP colon cancer in priority populations: pragmatic pilot study design and outcomes. BMC Cancer. 2014 Feb 26; 14:55.
Score: 0.316
-
Psychological distress after a positive fecal occult blood test result among members of an integrated healthcare delivery system. Cancer Epidemiol Biomarkers Prev. 2014 Jan; 23(1):154-9.
Score: 0.310
-
Uptake and positive predictive value of fecal occult blood tests: A randomized controlled trial. Prev Med. 2013 Nov; 57(5):671-8.
Score: 0.306
-
An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial. Ann Intern Med. 2013 Mar 05; 158(5 Pt 1):301-11.
Score: 0.296
-
Patients' Reactions to Being Offered Financial Incentives to Increase Colorectal Screening: A Qualitative Analysis. Am J Health Promot. 2021 03; 35(3):421-429.
Score: 0.128
-
Challenges in Reaching Medicaid and Medicare Enrollees in a Mailed Fecal Immunochemical Test Program. J Community Health. 2020 10; 45(5):916-921.
Score: 0.125
-
Barriers and Facilitators to Timely Colonoscopy Completion for Safety Net Clinic Patients. Am J Health Behav. 2020 07 01; 44(4):460-472.
Score: 0.123
-
Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention-sponsored Summit. CA Cancer J Clin. 2020 07; 70(4):283-298.
Score: 0.123
-
First-year implementation of mailed FIT colorectal cancer screening programs in two Medicaid/Medicare health insurance plans: qualitative learnings from health plan quality improvement staff and leaders. BMC Health Serv Res. 2020 Feb 21; 20(1):132.
Score: 0.120
-
Low Rates of Colonoscopy Follow-up After a Positive Fecal Immunochemical Test in a Medicaid Health Plan Delivered Mailed Colorectal Cancer Screening Program. J Prim Care Community Health. 2020 Jan-Dec; 11:2150132720958525.
Score: 0.119
-
Direct-to-member mailed colorectal cancer screening outreach for Medicaid and Medicare enrollees: Implementation and effectiveness outcomes from the BeneFIT study. Cancer. 2020 02 01; 126(3):540-548.
Score: 0.117
-
Predictors of Colorectal Cancer Screening Prior to Implementation of a Large Pragmatic Trial in Federally Qualified Health Centers. J Community Health. 2018 02; 43(1):128-136.
Score: 0.104
-
Applying the Plan-Do-Study-Act (PDSA) approach to a large pragmatic study involving safety net clinics. BMC Health Serv Res. 2017 06 19; 17(1):411.
Score: 0.100
-
The validation of electronic health records in accurately identifying patients eligible for colorectal cancer screening in safety net clinics. Fam Pract. 2016 12; 33(6):639-643.
Score: 0.094
-
Patterns of colorectal cancer screening uptake in newly eligible men and women. Cancer Epidemiol Biomarkers Prev. 2014 Jul; 23(7):1230-7.
Score: 0.080
-
Challenges and possible solutions to colorectal cancer screening for the underserved. J Natl Cancer Inst. 2014 Apr; 106(4):dju032.
Score: 0.080
-
Advantages of wordless instructions on how to complete a fecal immunochemical test: lessons from patient advisory council members of a federally qualified health center. J Cancer Educ. 2014 Mar; 29(1):86-90.
Score: 0.079
-
Physician-patient colorectal cancer screening discussions by physicians' screening rates. J Am Board Fam Med. 2012 Nov-Dec; 25(6):771-81.
Score: 0.072
-
Economic Evaluation of Mailed Home-Based Human Papillomavirus Self-sampling Kits for Cervical Cancer Screening. JAMA Netw Open. 2023 03 01; 6(3):e234052.
Score: 0.037
-
Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning Ten Years after a Negative Colonoscopy, among Screen-Eligible Adults 76 to 85 Years Old. Cancer Epidemiol Biomarkers Prev. 2023 01 09; 32(1):37-45.
Score: 0.037
-
Design of a pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake in a U.S. healthcare system: The STEP trial. Contemp Clin Trials. 2022 11; 122:106960.
Score: 0.036
-
Factors Influencing Implementation of a Colorectal Cancer Screening Improvement Program in Community Health Centers: an Applied Use of Configurational Comparative Methods. J Gen Intern Med. 2020 11; 35(Suppl 2):815-822.
Score: 0.031
-
Prospective Cohort study of Predictors of Follow-Up Diagnostic Colonoscopy from a Pragmatic Trial of FIT Screening. Sci Rep. 2020 02 12; 10(1):2441.
Score: 0.030
-
Taxonomy for colorectal cancer screening promotion: Lessons from recent randomized controlled trials. Prev Med. 2017 Aug; 101:229-234.
Score: 0.024